Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop by de Ruiter, Ruben D, Smilde, Bernard J, Pals, Gerard, Bravenboer, Nathalie, Knaus, Petra, Schoenmaker, Ton, Botman, Esmée, Sánchez-Duffhues, Gonzalo, Pacifici, Maurizio, Pignolo, Robert J, Shore, Eileen M, van Egmond, Marjolein, Van Oosterwyck, Hans, Kaplan, Frederick S, Hsiao, Edward C, Yu, Paul B, Bocciardi, Renata, De Cunto, Carmen Laura, Longo Ribeiro Delai, Patricia, de Vries, Teun J, Hilderbrandt, Susanne, Jaspers, Richard T, Keen, Richard, Koolwijk, Peter, Morhart, Rolf, Netelenbos, Jan C, Rustemeyer, Thomas, Scott, Christiaan, Stockklausner, Clemens, Ten Dijke, Peter, Triffit, James, Ventura, Francesc, Ravazzolo, Roberto, Micha, Dimitra, Eekhoff, Elisabeth M W

Get full text

Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva by Bravenboer, Nathalie, Micha, Dimitra, Triffit, James T, Bullock, Alex N, Ravazollo, Roberto, Bocciardi, Renata, di Rocco, Maja, Netelenbos, J Coen, Ten Dijke, Peter, Sánchez-Duffhues, Gonzalo, Kaplan, Fred S, Shore, Eileen M, Pignolo, Robert J, Seemann, Petra, Ventura, Francesc, Beaujat, Genevieve, Eekhoff, Elizabeth M W, Pals, Gerard

Get full text

Hydroxyapatite coated with insulin-like growth factor 1 (IGF1) stimulates human osteoblast activity in vitro by Zambonin, Giovanni, Grano, Maria, Greco, Giovanni, Oreffo, Richard O C, Triffit, James T

Get full text

Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies by Joyner, C.J., Bennett, A., Triffitt, J.T.

Get full text